Fifteen Connecticut companies made the 2025 Fortune 500 list of the largest U.S. corporations, which was announced Monday-- a sign of stability in the state's corporate sector. Bloomfield- ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the ...

Evernorth — the Cigna division that oversees the Express ... monthly copays for two popular weight-loss drugs, Wegovy and Zepbound, at $200. The impact on the employers' spending is unclear ...

The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna Group's Evernorth ...

An investigation by The Guardian finds the insurance giant UnitedHealth Group quietly paid thousands in bonuses to nursing home facilities that helped it gain Medicare enrollees and reduce ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an add-on to its pharmacy benefit management plans, the company announced on ...

Cigna’s (NYSE:CI) health services arm ... and Eli Lilly’s (NYSE:LLY) Zepbound. The monthly copay for GLP-1 weight loss medicines will be limited to no more than $200 under the new offering.

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...

Meanwhile, Eli Lilly and Novo Nordisk shares are down 6.8% and 22.1%, respectively, so far this year, while Cigna has risen 15.5% year-to-date. This content is provided by Stocktwits Wegovy, Zepbound ...

Cigna’s Evernorth has reached new deals with manufacturers ... The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 for participating patients. They also more deeply discount ...